Neoadjuvant Chemotherapy Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
Conditions:   Esophageal Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: Toripalimab;   Drug: Anlotinib hydrochloride;   Drug: Albumin paclitaxel;   Drug: Cisplatin Sponsor:   Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study
Conditions:   Locally Advanced Rectal Cancer;   Total Neoadjuvant Treatment;   Anti-PD-1 Intervention:   Other: nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W Sponsor:   The First Hospital of Jilin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma
Conditions:   Esophageal Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: Toripalimab;   Drug: Anlotinib hydrochloride;   Drug: Albumin paclitaxel;   Drug: Cisplatin Sponsor:   Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 17, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Conditions:   Head and Neck Squamous Cell Carcinoma;   Neoadjuvant Therapy Interventions:   Drug: 3cycles (Toripalimab + cetuximab);   Procedure: Surgery;   Radiation: Radiotherapy or chemoradiotherapy Sponsor:   Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials

Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Condition:   Breast Cancer Interventions:   Radiation: Arm I (No PMRT);   Radiation: Arm II (PMRT) Sponsor:   Gangnam Severance Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2023 Category: Research Source Type: clinical trials